Cells derived from human embryonic stem cells (hESCs) have been used to reverse retinal degeneration in an animal model.
Cells derived from human embryonic stem cells (hESCs) have been used to reverse retinal degeneration in an animal model. This news offers new hope that a cure for the devastating eye disease may be available in the near future.
In their laboratory, Dr. Benjamin Reubinoff, Dr. Eyal Banin, and their colleagues from Hadassah-Hebrew University Medical Center in Jerusalem developed conditions to guide hESCs to differentiate into functional cells that resembled the retinal pigment epithelium (RPE).
They found that nicotinamide (vitamin B3, NIC) and Activin A, an important growth factor, promoted differentiation of hESCs towards an RPE fate.
According to them, the hESC-derived cells exhibited the defining characteristics associated with RPE.
"Our findings are an important step towards the potential future use of hESCs to replenish RPE in blinding diseases," concludes Dr. Banin.
Advertisements
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia (CLL) is one of the most common types of adult leukemia and is considered as one of the ‘good cancers’.
Chronic Lymphocytic Leukemia (CLL) is one of the most common types of adult leukemia and is considered as one of the ‘good cancers’.
Source-ANI
RAS
Human Cord Blood can be Reprogrammed into Embryonic-Like Stem Cells
In two new studies researchers report that they have successfully reprogrammed human umbilical cord blood cells into cells with properties similar to human embryonic stem cells.
In two new studies researchers report that they have successfully reprogrammed human umbilical cord blood cells into cells with properties similar to human embryonic stem cells.
